Merus News
Most Popular Merus Story
Dutch biotech Merus lands $30.7M in Series B
Netherlands-based Merus has raised $30.7 million (€21.7 million) Series B financing. Merus says the funding will help it produce potent human antibody-based drugs. These drugs will either be Read more...
Latest Headlines
- January 29, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
